Literature DB >> 8662635

Domain structure of the vaccinia virus mRNA capping enzyme. Expression in Escherichia coli of a subdomain possessing the RNA 5'-triphosphatase and guanylyltransferase activities and a kinetic comparison to the full-size enzyme.

J R Myette1, E G Niles.   

Abstract

The RNA 5'-triphosphatase, nucleoside triphosphate phosphohydrolase, and guanylyltransferase activities of the vaccinia virus mRNA capping enzyme were previously localized to an NH2-terminal 60-kDa domain of the D1R subunit. Measurement of the relative ATPase and guanylyltransferase activities remaining in D1R carboxyl-terminal deletion variants expressed in Escherichia coli BL21(DE3)plysS localizes the carboxyl terminus of the active domain to between amino acids 520 and 545. Failure to obtain a deletion mutant with the loss of one activity indicates that the catalysis of both reactions requires a common domain structure. Based on these results, a truncated D1R protein terminating at amino acid 545 was expressed in E. coli and purified to homogeneity. D1R1-545 was found to be kinetically equivalent to the holoenzyme in regard to ATPase, RNA 5'-triphosphatase, and guanylyltransferase activities. Measurement of RNA binding by mobility shift and UV photo-cross-linking analyses also demonstrates the ability of this domain to bind RNA independent of the methyltransferase domain, comprised of the carboxyl terminus of D1R from amino acids 498-844 and the entire D12L subunit. RNA binding to D1R1-545 is substantially weaker than binding to either the methyltransferase domain or the holoenzyme. Binding is inhibited by 5'-OH RNA and to a lesser extent by DNA oligonucleotides in a concentration dependent manner which correlates with the inhibition of RNA 5'-triphosphatase activity by these same oligonucleotides. We conclude that D1R1-545 represents a functionally independent domain of the mRNA capping enzyme, fully competent in substrate binding and catalysis at both the triphosphatase and guanylyltransferase active sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662635     DOI: 10.1074/jbc.271.20.11936

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Phylogeny of mRNA capping enzymes.

Authors:  S P Wang; L Deng; C K Ho; S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

3.  A yeast-based genetic system for functional analysis of viral mRNA capping enzymes.

Authors:  C K Ho; A Martins; S Shuman
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus.

Authors:  Otto J P Kyrieleis; Jonathan Chang; Marcos de la Peña; Stewart Shuman; Stephen Cusack
Journal:  Structure       Date:  2014-03-04       Impact factor: 5.006

5.  RNA triphosphatase component of the mRNA capping apparatus of Paramecium bursaria Chlorella virus 1.

Authors:  C K Ho; C Gong; S Shuman
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.

Authors:  L Yu; A Martins; L Deng; S Shuman
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Genetic, physical, and functional interactions between the triphosphatase and guanylyltransferase components of the yeast mRNA capping apparatus.

Authors:  C K Ho; B Schwer; S Shuman
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Vaccinia virus early gene transcription termination factors VTF and Rap94 interact with the U9 termination motif in the nascent RNA in a transcription ternary complex.

Authors:  Linda A Christen; Sarah Piacente; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-05-01       Impact factor: 3.616

9.  Characterization of a mimivirus RNA cap guanine-N2 methyltransferase.

Authors:  Delphine Benarroch; Zhicheng R Qiu; Beate Schwer; Stewart Shuman
Journal:  RNA       Date:  2009-02-13       Impact factor: 4.942

10.  Characterization of a baculovirus-encoded RNA 5'-triphosphatase.

Authors:  C H Gross; S Shuman
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.